Related references
Note: Only part of the references are listed.Understanding and targeting the disease-related RNA binding protein human antigen R (HuR)
Christopher W. Schultz et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
ELAVL1 Role in Cell Fusion and Tunneling Membrane Nanotube Formations with Implication to Treat Glioma Heterogeneity
Natalia Filippova et al.
CANCERS (2020)
Anti-cancer effects of the HuR inhibitor, MS-444, in malignant glioma cells
Jiping Wang et al.
CANCER BIOLOGY & THERAPY (2019)
Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth
Jiping Wang et al.
GLIA (2019)
Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data
Wei Yang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
mTORC2/AKT/HSF1/HuR constitute a feed-forward loop regulating Rictor expression and tumor growth in glioblastoma
B. Holmes et al.
ONCOGENE (2018)
Clinical Significance and Biological Role of HuR in Head and Neck Carcinomas
Georgia Levidou et al.
DISEASE MARKERS (2018)
The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
Yanqing Liu et al.
MOLECULAR CANCER (2018)
Complex HuR function in pancreatic cancer cells
Jonathan R. Brody et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2018)
New insigts into the cellular temporal response to proteostatic stress
Justin Rendleman et al.
ELIFE (2018)
Suramin, screened from an approved drug library, inhibits HuR functions and attenuates malignant phenotype of oral cancer cells
Wataru Kakuguchi et al.
CANCER MEDICINE (2018)
Repression of caspase-3 and RNA-binding protein HuR cleavage by cyclooxygenase-2 promotes drug resistance in oral squamous cell carcinoma
H. Janakiraman et al.
ONCOGENE (2017)
Hu antigen R (HuR) multimerization contributes to glioma disease progression
Natalia Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR
Ranganayaki Muralidharan et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Regulation of HuR structure and function by dihydrotanshinone-I
Preet Lal et al.
NUCLEIC ACIDS RESEARCH (2017)
The fungal natural product azaphilone-9 binds to HuR and inhibits HuR-RNA interaction in vitro
Kawaljit Kaur et al.
PLOS ONE (2017)
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells
Ranganayaki Muralidharan et al.
SCIENTIFIC REPORTS (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
Systematic Analysis of AU-Rich Element Expression in Cancer Reveals Common Functional Clusters Regulated by Key RNA-Binding Proteins
Edward Hitti et al.
CANCER RESEARCH (2016)
PKM2 uses control of HuR localization to regulate p27 and cell cycle progression in human glioblastoma cells
Joydeep Mukherjee et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Dual mechanisms of action of the RNA-binding protein human antigen R explains its regulatory effect on melanoma cell migration
Farnaz Moradi et al.
TRANSLATIONAL RESEARCH (2016)
Impact of HuR inhibition by the small molecule MS-444 on colorectal cancer cell tumorigenesis
Fernando F. Blanco et al.
ONCOTARGET (2016)
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration
Ranganayaki Muralidharan et al.
JOURNAL OF NANOBIOTECHNOLOGY (2016)
Modeling Chemotherapeutic Neurotoxicity with Human Induced Pluripotent Stem Cell-Derived Neuronal Cells
Heather E. Wheeler et al.
PLOS ONE (2015)
Dihydrotanshinone-I interferes with the RNA-binding activity of HuR affecting its post-transcriptional function
Vito Giuseppe D'Agostino et al.
Scientific Reports (2015)
Molecular heterogeneity in glioblastoma: potential clinical implications
Nicole Renee Parker et al.
FRONTIERS IN ONCOLOGY (2015)
Growth Factor Dependent Regulation of Centrosome Function and Genomic Instability by HuR
Natalia Filippova et al.
BIOMOLECULES (2015)
Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and Prognosis
Jun Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Regulation of the mRNA-Binding Protein HuR by Posttranslational Modification: Spotlight on Phosphorylation
Wolfgang Eberhardt et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2012)
Phosphoregulation of the RNA-binding Protein Hu Antigen R (HuR) by Cdk5 Affects Centrosome Function
Natalia Filippova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
mRNA stability alterations mediated by HuR are necessary to sustain the fast growth of glioma cells
Federico Bolognani et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
The RNA-Binding Protein HuR Promotes Glioma Growth and Treatment Resistance
Natalia Filippova et al.
MOLECULAR CANCER RESEARCH (2011)
Posttranscriptional regulation of cancer traits by HuR
Kotb Abdelmohsen et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2010)
Chemical inhibitors destabilize HuR binding to the AU-rich element of TNF-α mRNA
Min-Ju Chae et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Cytoplasmic accumulation of the RNA binding protein HuR is central to tamoxifen resistance in estrogen receptor positive breast cancer cells
Christine Hostetter et al.
CANCER BIOLOGY & THERAPY (2008)
Caspase-mediated cleavage of HuR in the cytoplasm contributes to pp32/PHAP-I regulation of apoptosis
Rachid Mazroui et al.
JOURNAL OF CELL BIOLOGY (2008)
Identification and mechanistic characterization of low-molecular-weight inhibitors for HuR
Nicole-Claudia Meisner et al.
NATURE CHEMICAL BIOLOGY (2007)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The prognostic influence of bcl-2 in malignant glioma
FE McDonald et al.
BRITISH JOURNAL OF CANCER (2002)
HuR regulates cyclin A and cyclin B1 mRNA stability during cell proliferation
WG Wang et al.
EMBO JOURNAL (2000)
Share Paper
